Filter By Industry
Filter By Tag


BOC Sciences Press releases

11 - 20 of 33 Press Releases

Feb 23, 2022
BOC Sciences, a New York-based company with a long-term commitment to providing pharmaceutical discovery services and raw materials, recently introduces pharmaceutical impurity identification services to accelerate drug development.

Feb 11, 2022
BOC RNA, a sub-brand of BOC Sciences, has been contributing to the development of siRNA drug delivery system for years and provides a series of siRNA conjugates. siRNA drugs demonstrate promising prospects in clinical practice.

Jan 19, 2022
AAPEP, a sub-brand of BOC Sciences, is an experienced biochemistry company, which offers a complete range of amino acid products, including natural amino acids and unnatural amino acids, for chemical and biochemical laboratory and scientific use.

Jan 07, 2022
In the process of drug research, production, storage, and clinical application, its impurity contents must be reduced to ensure effectiveness and safety.

Dec 24, 2021
BOC Sciences, well known as the largest supplier of pseudoUridine in the world, announces that its yearly output currently surpasses 500 kg, indicating reliable efficiency and high productivity.

Dec 12, 2021
The principle of high-throughput drug screening is that drugs mostly re-adjust the patient's physiological state by specifically acting on target proteins (receptors, enzymes, ion channels, etc.).

Dec 05, 2021
BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide a comprehensive one-stop industrial fermentation CDMO service.

Oct 22, 2021
BOC Sciences, a New York-based provider of microbial metabolite products and services, recently announced that it has expanded its service range to provide fermentation process optimization services for the development and production of microbial...

Sep 29, 2021
Antibody-drug conjugates (ADCs) are conjugates of cytotoxic small-molecule drugs with targeted monoclonal antibodies through a linker. The specificity of antibodies reduces the toxicity of small-molecule drugs and increases the therapeutic window.

Sep 16, 2021
RNA is a hydrophilic, negatively charged macromolecule, and its ability to autonomously transmembrane is limited.

Page: Prev 1 2 3 4 Next
BOC Sciences RSS Feed